欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0517/001
药品名称Salmeterol plus Fluticasone propionate 25/125 micrograms per dose Pressurised inhalation,suspension
活性成分
    • fluticasone propionate 125.0 µg/dose
    • salmeterol xinafoat 25.0 µg/dose
剂型Pressurised inhalation, suspension
上市许可持有人Cipla Europe NV Uitbreidingstraat 80 2600 Antwerp Belgien
参考成员国 - 产品名称Austria (AT)
Zoreeda 25 Mikrogramm/125 Mikrogramm pro Dosis - Druckgasinhalation, Suspension
互认成员国 - 产品名称
    • Italy (IT)
    • Norway (NO)
      Salmeterol/Fluticasone Cipla
    • Finland (FI)
    • Romania (RO)
      Serroflo 25 micrograme/125 micrograme/doză suspensie de inhalat presurizată
    • Croatia (HR)
    • Hungary (HU)
许可日期2014/08/04
最近更新日期2024/03/22
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase